These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24319728)

  • 1. Anti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible toxic pneumofibrosis.
    Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Reihard DV; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2013 Nov; 156(1):53-8. PubMed ID: 24319728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic activity of hyaluronidase immobilized on polyethylenoxide under conditions of bleomycin-induced pneumofibrosis.
    Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2013 Jan; 154(3):388-92. PubMed ID: 23484207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrotic effect of combined treatment with neuroleptic drug and immobilized hyaluronidase in pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Semiglazova TA
    Bull Exp Biol Med; 2013 Jan; 154(3):329-33. PubMed ID: 23484193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium.
    Dygai AM; Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2013 Aug; 155(4):501-6. PubMed ID: 24143378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
    Skurikhin EG; Pershina OV; Reztsova AM; Ermakova NN; Khmelevskaya ES; Krupin VA; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Dygai AM
    PLoS One; 2015; 10(4):e0125065. PubMed ID: 25927611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis.
    Skurikhin E; Madonov P; Pershina O; Ermakova N; Pakhomova A; Widera D; Pan E; Zhukova M; Sandrikina L; Artamonov A; Dygai A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of spiperone on mesenchymal multipotent stromal and hemopoietic stem cells under conditions of pulmonary fibrosis.
    Skurikhin EG; Khmelevskaya ES; Ermakova NN; Pershina OV; Reztsova AM; Krupin VA; Stepanova IE; Reztsova VM; Reikhart DV; Dygai AM
    Bull Exp Biol Med; 2014 May; 157(1):132-7. PubMed ID: 24913578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immobilized hyaluronidase on stem and progenitor cells in pulmonary fibrosis.
    Dygai AM; Skurikhin EG; Khmelevskaya ES; Ermakova NN; Reztsova AM; Pershina OV; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
    Bull Exp Biol Med; 2014 Feb; 156(4):590-4. PubMed ID: 24771454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the anti-inflammatory and antifibrotic activity of a sympatholytic agent during toxic pulmonary fibrosis.
    Skurikhin EG; Khmelevskaya ES; Pershina OV; Andreeva TV; Ermolaeva LA; Krupin VA; Ermakova NN; Reztsova AM; Stepanova IE; Dygai AM
    Bull Exp Biol Med; 2012 Sep; 153(5):638-43. PubMed ID: 23113245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
    Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
    Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic activity of conjugates based on amphiphilic pluronic F68 and hydrophobic pluronic L31 with hyaluronate-endo-β-N-acetylhexosaminidase in pulmonary fibrosis.
    Skurikhin EG; Reztsova AM; Ermakova NN; Krupin VA; Pershina OV; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Reykhard DV; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2014 May; 157(1):5-9. PubMed ID: 24906958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
    Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
    Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
    Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
    Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E
    J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
    Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.
    Takemasa A; Ishii Y; Fukuda T
    Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.
    Chilakapati SR; Serasanambati M; Manikonda PK; Chilakapati DR; Watson RR
    Can J Physiol Pharmacol; 2014 Aug; 92(8):631-9. PubMed ID: 24933624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.